Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531 NCT01407757 Leukemia
DNA analysis
gene expression...
laboratory biom...
pharmacogenomic...
- 29 Years Children's Oncology Group View Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia NCT00003758 Leukemia
cytarabine
idarubicin
allogeneic bone...
autologous bone...
peripheral bloo...
15 Years - 60 Years National Cancer Institute (NCI) View Biomarkers in Predicting Response to Treatment in Bone Marrow Samples From Young Patients With Acute Myeloid Leukemia NCT01321385 Leukemia
laboratory biom...
study of socioe...
- 21 Years Children's Oncology Group View Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia NCT00009698 Leukemia
aldesleukin
- 21 Years Children's Oncology Group View Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia NCT00003405 Leukemia
recombinant int...
amifostine trih...
bromodeoxyuridi...
cytarabine
idarubicin
idoxuridine
isotretinoin
mitoxantrone hy...
0 Years - 70 Years Rush University Medical Center View Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome NCT00002547 Leukemia
Myelodysplastic...
busulfan
cyclophosphamid...
cyclosporine
cytarabine
methotrexate
allogeneic bone...
syngeneic bone ...
- 60 Years Barbara Ann Karmanos Cancer Institute View Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome NCT00002798 Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Myelo...
Chronic Myelomo...
de Novo Myelody...
Refractory Anem...
Refractory Anem...
Refractory Anem...
Refractory Anem...
Secondary Myelo...
Untreated Child...
asparaginase
daunorubicin hy...
fludarabine pho...
therapeutic hyd...
allogeneic bone...
3-dimensional c...
filgrastim
cytarabine
idarubicin
dexamethasone
thioguanine
etoposide
methotrexate
cyclophosphamid...
aldesleukin
busulfan
- 21 Years National Cancer Institute (NCI) View Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia NCT00006363 Adult Acute Bas...
Adult Acute Eos...
Adult Acute Ery...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Myelo...
de Novo Myelody...
Untreated Adult...
Untreated Child...
cytarabine
daunorubicin hy...
etoposide
valspodar
filgrastim
busulfan
autologous hema...
peripheral bloo...
aldesleukin
clinical observ...
pharmacological...
15 Years - 59 Years National Cancer Institute (NCI) View Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia NCT01076569 Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Recurrent Child...
Untreated Child...
laboratory biom...
- 21 Years Children's Oncology Group View Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia NCT00003405 Leukemia
recombinant int...
amifostine trih...
bromodeoxyuridi...
cytarabine
idarubicin
idoxuridine
isotretinoin
mitoxantrone hy...
0 Years - 70 Years Rush University Medical Center View Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia NCT00666588 Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Recurrent Adult...
Recurrent Child...
Secondary Acute...
idarubicin
cytarabine
bortezomib
etoposide
laboratory biom...
1 Year - 21 Years National Cancer Institute (NCI) View Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid Leukemia NCT00004056 Leukemia
filgrastim
asparaginase
cytarabine
daunorubicin hy...
melphalan
thioguanine
peripheral bloo...
- 21 Years Children's Oncology Group View Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia NCT01146210 Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Myelo...
Chronic Myelomo...
de Novo Myelody...
Fanconi Anemia
Refractory Anem...
Refractory Anem...
Refractory Anem...
Refractory Anem...
Secondary Myelo...
Untreated Child...
laboratory biom...
- 21 Years Children's Oncology Group View Chemotherapy in Treating Children With Recurrent Acute Myeloid Leukemia NCT00003178 Leukemia
filgrastim
cladribine
idarubicin
- 21 Years Children's Oncology Group View Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy NCT00070174 Leukemia
asparaginase
busulfan
cyclophosphamid...
cyclosporine
cytarabine
daunorubicin hy...
etoposide
gemtuzumab ozog...
methotrexate
mitoxantrone hy...
allogeneic bone...
- Children's Oncology Group View Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia NCT00372593 Leukemia
asparaginase
cytarabine
daunorubicin hy...
etoposide
gemtuzumab ozog...
mitoxantrone hy...
- 29 Years Children's Oncology Group View Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy NCT00070174 Leukemia
asparaginase
busulfan
cyclophosphamid...
cyclosporine
cytarabine
daunorubicin hy...
etoposide
gemtuzumab ozog...
methotrexate
mitoxantrone hy...
allogeneic bone...
- Children's Oncology Group View Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia NCT00003758 Leukemia
cytarabine
idarubicin
allogeneic bone...
autologous bone...
peripheral bloo...
15 Years - 60 Years National Cancer Institute (NCI) View Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia NCT00006363 Adult Acute Bas...
Adult Acute Eos...
Adult Acute Ery...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Myelo...
de Novo Myelody...
Untreated Adult...
Untreated Child...
cytarabine
daunorubicin hy...
etoposide
valspodar
filgrastim
busulfan
autologous hema...
peripheral bloo...
aldesleukin
clinical observ...
pharmacological...
15 Years - 59 Years National Cancer Institute (NCI) View Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome NCT00005593 Leukemia
Myelodysplastic...
carboplatin
fludarabine pho...
topotecan hydro...
12 Years - Case Comprehensive Cancer Center View Study to Predict Risk of Relapse in Bone Marrow Cell Samples From Younger Patients With Acute Myeloid Leukemia NCT01438138 Leukemia
diagnostic labo...
- 21 Years Children's Oncology Group View Study to Predict Risk of Relapse in Bone Marrow Cell Samples From Younger Patients With Acute Myeloid Leukemia NCT01438138 Leukemia
diagnostic labo...
- 21 Years Children's Oncology Group View Ex Vivo Expansion of Mafosfamide Purged CD34+ Cells in Patients With Acute Leukemia NCT00245115 Leukemia
filgrastim
busulfan
cyclophosphamid...
in vitro-treate...
in vitro-treate...
- 70 Years Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins View Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia NCT01076569 Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Recurrent Child...
Untreated Child...
laboratory biom...
- 21 Years Children's Oncology Group View Biomarkers in Predicting Response to Treatment in Bone Marrow Samples From Young Patients With Acute Myeloid Leukemia NCT01321385 Leukemia
laboratory biom...
study of socioe...
- 21 Years Children's Oncology Group View Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome NCT00005593 Leukemia
Myelodysplastic...
carboplatin
fludarabine pho...
topotecan hydro...
12 Years - Case Comprehensive Cancer Center View